{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:24:11Z","timestamp":1793676251438,"version":"4.5.1"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07786-y","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:33:27Z","timestamp":1770197607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stromal cells contribute to progression, recurrence, and metastasis in oral squamous cell carcinoma: a call for therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Jessica","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Zakershahrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh D.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-1208","authenticated-orcid":false,"given":"Chider","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"7786_CR1","doi-asserted-by":"publisher","unstructured":"Li Y, Gao S, Hu Q, Wu F. Functional properties of cancer epithelium and stroma-derived exosomes in head and neck squamous cell carcinoma. Life (Basel). 2022;12(5). https:\/\/doi.org\/10.3390\/life12050757.","DOI":"10.3390\/life12050757"},{"issue":"1","key":"7786_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92. https:\/\/doi.org\/10.1038\/s41572-020-00224-3.","journal-title":"Nat Rev Dis Primers"},{"key":"7786_CR3","doi-asserted-by":"publisher","first-page":"100831","DOI":"10.1016\/j.ctarc.2024.100831","volume":"40","author":"D Swaminathan","year":"2024","unstructured":"Swaminathan D, George NA, Thomas S, Iype EM. Factors associated with delay in diagnosis of oral cancers. Cancer Treat Res Commun. 2024;40:100831. https:\/\/doi.org\/10.1016\/j.ctarc.2024.100831.","journal-title":"Cancer Treat Res Commun"},{"issue":"1","key":"7786_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7786_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13046-024-03141-5","volume":"43","author":"I Gupta","year":"2024","unstructured":"Gupta I, Badrzadeh F, Tsentalovich Y, Gaykalova DA. Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma. J Exp Clin Cancer Res. 2024;43(1):239. https:\/\/doi.org\/10.1186\/s13046-024-03141-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"Pt 1","key":"7786_CR6","doi-asserted-by":"publisher","first-page":"116751","DOI":"10.1016\/j.envres.2023.116751","volume":"239","author":"L Qin","year":"2023","unstructured":"Qin L, Wu J. Targeting anticancer immunity in oral cancer: drugs, products, and nanoparticles. Environ Res. 2023;239(Pt 1):116751. https:\/\/doi.org\/10.1016\/j.envres.2023.116751.","journal-title":"Environ Res"},{"key":"7786_CR7","doi-asserted-by":"publisher","unstructured":"Mauceri R, Bazzano M, Coppini M, Tozzo P, Panzarella V, Campisi G. Diagnostic delay of oral squamous cell carcinoma and the fear of diagnosis: a scoping review. Front Psychol. 2022;13(1009080). https:\/\/doi.org\/10.3389\/fpsyg.2022.1009080.","DOI":"10.3389\/fpsyg.2022.1009080"},{"issue":"Suppl 8","key":"7786_CR8","doi-asserted-by":"publisher","first-page":"viii6","DOI":"10.1093\/annonc\/mds256","volume":"8","author":"OJ Finn","year":"2012","unstructured":"Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol, 23 Suppl 2012;8(Suppl 8):viii6\u20139. https:\/\/doi.org\/10.1093\/annonc\/mds256.","journal-title":"Ann Oncol"},{"issue":"2","key":"7786_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10555-010-9222-7","volume":"29","author":"SA Bergfeld","year":"2010","unstructured":"Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010;29(2):249\u201361. https:\/\/doi.org\/10.1007\/s10555-010-9222-7.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"7786_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13402-018-0388-2","volume":"41","author":"P Nilendu","year":"2018","unstructured":"Nilendu P, Sarode SC, Jahagirdar D, Tandon I, Patil S, Sarode GS, et al. Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance. Cell Oncol (Dordr). 2018;41(4):353\u201367. https:\/\/doi.org\/10.1007\/s13402-018-0388-2.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"7786_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/scrt484","volume":"5","author":"BA Kansy","year":"2014","unstructured":"Kansy BA, Di\u00dfmann PA, Hemeda H, Bruderek K, Westerkamp AM, Jagalski V, et al. The bidirectional tumor-mesenchymal stromal cell interaction promotes the progression of head and neck cancer. STEM Cell Res Ther. 2014;5(4):95. https:\/\/doi.org\/10.1186\/scrt484.","journal-title":"STEM Cell Res Ther"},{"issue":"6","key":"7786_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/his.14070","volume":"76","author":"MR Dourado","year":"2020","unstructured":"Dourado MR, Miwa KYM, Hamada GB, Parana\u00edba LMR, Sawazaki-Calone \u00cd, Domingueti CB, et al. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding. Histopathology. 2020;76(6):906\u201318. https:\/\/doi.org\/10.1111\/his.14070.","journal-title":"Histopathology"},{"issue":"7","key":"7786_CR13","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/odi.15278","volume":"31","author":"EF de Morais","year":"2025","unstructured":"de Morais EF, M\u00e4kitie A, Coletta RD, Almangush A. Stromal prognostic markers for oral cancer: an update. Oral Dis. 2025;31(7):2019\u201325. https:\/\/doi.org\/10.1111\/odi.15278.","journal-title":"Oral Dis"},{"issue":"5","key":"7786_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/his.14202","volume":"77","author":"M Mascitti","year":"2020","unstructured":"Mascitti M, Zhurakivska K, Togni L, Caponio VCA, Almangush A, Balercia P, et al. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma. Histopathology. 2020;77(5):810\u201322. https:\/\/doi.org\/10.1111\/his.14202.","journal-title":"Histopathology"},{"issue":"1","key":"7786_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12967-016-1091-6","volume":"14","author":"TL Watts","year":"2016","unstructured":"Watts TL, Cui R, Szaniszlo P, Resto VA, Powell DW, Pinchuk IV. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment. J Transl Med. 2016;14(1):337. https:\/\/doi.org\/10.1186\/s12967-016-1091-6.","journal-title":"J Transl Med"},{"issue":"3","key":"7786_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41416-021-01626-0","volume":"126","author":"V Mishra","year":"2022","unstructured":"Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, et al. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022;126(3):361\u201370. https:\/\/doi.org\/10.1038\/s41416-021-01626-0.","journal-title":"Br J Cancer"},{"issue":"1","key":"7786_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJMoa2415434","volume":"393","author":"R Uppaluri","year":"2025","unstructured":"Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, et al. Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N Engl J Med. 2025;393(1):37\u201350. https:\/\/doi.org\/10.1056\/NEJMoa2415434.","journal-title":"N Engl J Med"},{"key":"7786_CR18","doi-asserted-by":"publisher","first-page":"930988","DOI":"10.3389\/fonc.2022.930988","volume":"12","author":"M Pei","year":"2022","unstructured":"Pei M, Han D, Kim KY, Kim DW, Nam W, Kim HJ, et al. Risk factors of microscopically tumor-free surgical margins for recurrence and survival of oral squamous cell carcinoma patients. Front Oncol. 2022;12:930988. https:\/\/doi.org\/10.3389\/fonc.2022.930988.","journal-title":"Front Oncol"},{"key":"7786_CR19","doi-asserted-by":"publisher","unstructured":"Buruian\u0103 A, Gheban BA, Gheban-Ro\u0219ca IA, Georgiu C, Cri\u0219an D, Cri\u0219an M. The tumor stroma of squamous cell carcinoma: a complex environment that fuels cancer progression. Cancers (Basel). 2024;16(9). https:\/\/doi.org\/10.3390\/cancers16091727.","DOI":"10.3390\/cancers16091727"},{"issue":"2","key":"7786_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik A, Genov\u00e9 G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193\u2013215. https:\/\/doi.org\/10.1016\/j.devcel.2011.07.001.","journal-title":"Dev Cell"},{"issue":"4","key":"7786_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/s1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005;7(4):452\u201364. https:\/\/doi.org\/10.1215\/s1152851705000232.","journal-title":"Neuro Oncol"},{"issue":"4","key":"7786_CR22","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s12105-020-01188-2","volume":"14","author":"IB Valle","year":"2020","unstructured":"Valle IB, Schuch LF, da Silva JM, Gala-Garc\u00eda A, Diniz IMA, Birbrair A, et al. Pericyte in oral squamous cell carcinoma: a systematic review. Head Neck Pathol. 2020;14(4):1080\u201391. https:\/\/doi.org\/10.1007\/s12105-020-01188-2.","journal-title":"Head Neck Pathol"},{"key":"7786_CR23","doi-asserted-by":"publisher","unstructured":"Jiang Z, Zhou J, Li L, Liao S, He J, Zhou S, et al. Pericytes in the tumor microenvironment. Cancer Lett. 2023;556(216074). https:\/\/doi.org\/10.1016\/j.canlet.2023.216074.","DOI":"10.1016\/j.canlet.2023.216074"},{"issue":"24","key":"7786_CR24","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1182\/blood-2009-05-222364","volume":"114","author":"AN Stratman","year":"2009","unstructured":"Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood. 2009;114(24):5091\u2013101. https:\/\/doi.org\/10.1182\/blood-2009-05-222364.","journal-title":"Blood"},{"key":"7786_CR25","doi-asserted-by":"publisher","first-page":"676342","DOI":"10.3389\/fcell.2021.676342","volume":"9","author":"R Sun","year":"2021","unstructured":"Sun R, Kong X, Qiu X, Huang C, Wong PP. The emerging roles of pericytes in modulating tumor microenvironment. Front Cell Dev Biol. 2021;9:676342. https:\/\/doi.org\/10.3389\/fcell.2021.676342.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"7786_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s13402-021-00602-3","volume":"44","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor J, Mortezaee K. Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr). 2021;44(4):715\u201337. https:\/\/doi.org\/10.1007\/s13402-021-00602-3.","journal-title":"Cell Oncol (Dordr)"},{"issue":"10","key":"7786_CR27","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm.4400","volume":"23","author":"M Murgai","year":"2017","unstructured":"Murgai M, Ju W, Eason M, Kline J, Beury DW, Kaczanowska S, et al. KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis. Nat Med. 2017;23(10):1176\u201390. https:\/\/doi.org\/10.1038\/nm.4400.","journal-title":"Nat Med"},{"issue":"10","key":"7786_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41422-021-00528-3","volume":"31","author":"XN Zhang","year":"2021","unstructured":"Zhang XN, Yang KD, Chen C, He ZC, Wang QH, Feng H, et al. Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling. Cell Res. 2021;31(10):1072\u201387. https:\/\/doi.org\/10.1038\/s41422-021-00528-3.","journal-title":"Cell Res"},{"key":"7786_CR29","doi-asserted-by":"publisher","unstructured":"Ribeiro AL, Okamoto OK. Combined effects of pericytes in the tumor microenvironment. STEM Cells Int. 2015, 2015;868475. https:\/\/doi.org\/10.1155\/2015\/868475.","DOI":"10.1155\/2015\/868475"},{"issue":"2","key":"7786_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10555-021-09958-2","volume":"40","author":"V Delprat","year":"2021","unstructured":"Delprat V, Michiels C. A bi-directional dialog between vascular cells and monocytes\/macrophages regulates tumor progression. Cancer Metastasis Rev. 2021;40(2):477\u2013500. https:\/\/doi.org\/10.1007\/s10555-021-09958-2.","journal-title":"Cancer Metastasis Rev"},{"key":"7786_CR31","doi-asserted-by":"publisher","unstructured":"Wang Y, Sun Q, Ye Y, Sun X, Xie S, Zhan Y, et al. FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis. JCI Insight. 2022;7(10). https:\/\/doi.org\/10.1172\/jci.insight.157874.","DOI":"10.1172\/jci.insight.157874"},{"issue":"11","key":"7786_CR32","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1172\/jci86623","volume":"126","author":"AK Shenoy","year":"2016","unstructured":"Shenoy AK, Jin Y, Luo H, Tang M, Pampo C, Shao R, et al. Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells. J Clin Invest. 2016;126(11):4174\u201386. https:\/\/doi.org\/10.1172\/jci86623.","journal-title":"J Clin Invest"},{"issue":"1","key":"7786_CR33","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1038\/s41598-023-32528-1","volume":"13","author":"IB Valle","year":"2023","unstructured":"Valle IB, Oliveira SR, da Silva JM, Peterle GT, C\u00f3 ACG, Sousa-Neto SS, et al. The participation of tumor residing pericytes in oral squamous cell carcinoma. Sci Rep. 2023;13(1):5460. https:\/\/doi.org\/10.1038\/s41598-023-32528-1.","journal-title":"Sci Rep"},{"issue":"5","key":"7786_CR34","first-page":"1388","volume":"60","author":"A Eberhard","year":"2000","unstructured":"Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000;60(5):1388\u201393.","journal-title":"Cancer Res"},{"issue":"3","key":"7786_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.oraloncology.2007.02.007","volume":"44","author":"SY Liu","year":"2008","unstructured":"Liu SY, Chang LC, Pan LF, Hung YJ, Lee CH, Shieh YS. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol. 2008;44(3):277\u201385. https:\/\/doi.org\/10.1016\/j.oraloncology.2007.02.007.","journal-title":"Oral Oncol"},{"issue":"3","key":"7786_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/s0002-9440(10)64920-6","volume":"160","author":"S Morikawa","year":"2002","unstructured":"Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol. 2002;160(3):985\u20131000. https:\/\/doi.org\/10.1016\/s0002-9440(10)64920-6.","journal-title":"Am J Pathol"},{"issue":"6","key":"7786_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hed.21814","volume":"34","author":"D Hollemann","year":"2012","unstructured":"Hollemann D, Yanagida G, R\u00fcger BM, Neuchrist C, Fischer MB. New vessel formation in peritumoral area of squamous cell carcinoma of the head and neck. Head Neck. 2012;34(6):813\u201320. https:\/\/doi.org\/10.1002\/hed.21814.","journal-title":"Head Neck"},{"issue":"2","key":"7786_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12032-013-0571-2","volume":"30","author":"C Li","year":"2013","unstructured":"Li C, Sun CJ, Fan JC, Geng N, Li CH, Liao J, et al. Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma. Med Oncol. 2013;30(2):571. https:\/\/doi.org\/10.1007\/s12032-013-0571-2.","journal-title":"Med Oncol"},{"issue":"38","key":"7786_CR39","doi-asserted-by":"publisher","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","volume":"113","author":"K Hosaka","year":"2016","unstructured":"Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci U S A. 2016;113(38):E5618\u20135627. https:\/\/doi.org\/10.1073\/pnas.1608384113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"7786_CR40","doi-asserted-by":"publisher","first-page":"51591","DOI":"10.18632\/oncotarget.18196","volume":"8","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wang Y, Rashid MH, Liu M, Angara K, Mivechi NF, et al. Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis. Oncotarget. 2017;8(31):51591\u2013607. https:\/\/doi.org\/10.18632\/oncotarget.18196.","journal-title":"Oncotarget"},{"issue":"2","key":"7786_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/1061186x.2018.1497040","volume":"27","author":"AC Prince","year":"2019","unstructured":"Prince AC, Patel NG, Moore LS, McGee AS, Ahn JC, Willey CD, et al. Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer(). J Drug Target. 2019;27(2):193\u2013200. https:\/\/doi.org\/10.1080\/1061186x.2018.1497040.","journal-title":"J Drug Target"},{"issue":"5","key":"7786_CR42","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/15384047.2015.1016664","volume":"16","author":"TK Chung","year":"2015","unstructured":"Chung TK, Warram J, Day KE, Hartman Y, Rosenthal EL. Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies. Cancer Biol Ther. 2015;16(5):790\u201398. https:\/\/doi.org\/10.1080\/15384047.2015.1016664.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"7786_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2217\/fon.14.123","volume":"11","author":"MB Meng","year":"2015","unstructured":"Meng MB, Zaorsky NG, Deng L, Wang HH, Chao J, Zhao LJ, et al. Pericytes: a double-edged sword in cancer therapy. Future Oncol. 2015;11(1):169\u201379. https:\/\/doi.org\/10.2217\/fon.14.123.","journal-title":"Future Oncol"},{"issue":"1","key":"7786_CR44","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1002\/mog2.68","volume":"3","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang Z, Liu K, Liu Y, Wang S, Jiang W, et al. Targets of tumor microenvironment for potential drug development. MedComm-Oncology. 2024;3(1):e68.","journal-title":"MedComm-Oncology"},{"issue":"5","key":"7786_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2017.10.002","volume":"21","author":"W Zhou","year":"2017","unstructured":"Zhou W, Chen C, Shi Y, Wu Q, Gimple RC, Fang X, et al. Targeting glioma stem cell-derived pericytes disrupts the blood-tumor barrier and improves chemotherapeutic efficacy. Cell STEM Cell. 2017;21(5):591\u2013603. e594.","journal-title":"Cell STEM Cell"},{"issue":"Suppl 4","key":"7786_CR46","doi-asserted-by":"publisher","first-page":"138s","DOI":"10.1111\/j.1537-2995.2011.03376.x","volume":"4","author":"P Hematti","year":"2011","unstructured":"Hematti P. Human embryonic stem cell-derived mesenchymal stromal cells. Transfusion, 51 Suppl 2011;4(Suppl 4):138s\u201344s. https:\/\/doi.org\/10.1111\/j.1537-2995.2011.03376.x.","journal-title":"Transfusion"},{"key":"7786_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0076-6879(06)20016-8","volume":"420","author":"NW Marion","year":"2006","unstructured":"Marion NW, Mao JJ. Mesenchymal stem cells and tissue engineering. Methods Enzymol. 2006;420:339\u201361. https:\/\/doi.org\/10.1016\/s0076-6879(06)20016-8.","journal-title":"Methods Enzymol"},{"key":"7786_CR48","doi-asserted-by":"publisher","first-page":"112269","DOI":"10.1016\/j.biopha.2021.112269","volume":"144","author":"MC de Miranda","year":"2021","unstructured":"de Miranda MC, Melo MIA, Cunha PDS, Gentilini JJ, Faria J, Rodrigues MA, et al. Roles of mesenchymal stromal cells in the head and neck cancer microenvironment. Biomed Pharmacother. 2021;144:112269. https:\/\/doi.org\/10.1016\/j.biopha.2021.112269.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"7786_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u201317. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"issue":"1","key":"7786_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","volume":"14","author":"T Lan","year":"2021","unstructured":"Lan T, Luo M, Wei X. Mesenchymal stem\/stromal cells in cancer therapy. J Hematol Oncol. 2021;14(1):195. https:\/\/doi.org\/10.1186\/s13045-021-01208-w.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"7786_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/bjc.2015.15","volume":"112","author":"F Liotta","year":"2015","unstructured":"Liotta F, Querci V, Mannelli G, Santarlasci V, Maggi L, Capone M, et al. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation. Br J Cancer. 2015;112(4):745\u201354. https:\/\/doi.org\/10.1038\/bjc.2015.15.","journal-title":"Br J Cancer"},{"issue":"9","key":"7786_CR52","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0022034509340867","volume":"88","author":"GT Huang","year":"2009","unstructured":"Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res. 2009;88(9):792\u2013806. https:\/\/doi.org\/10.1177\/0022034509340867.","journal-title":"J Dent Res"},{"issue":"11","key":"7786_CR53","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1177\/0022034512461016","volume":"91","author":"QZ Zhang","year":"2012","unstructured":"Zhang QZ, Nguyen AL, Yu WH, Le AD. Human oral mucosa and gingiva: a unique reservoir for mesenchymal stem cells. J Dent Res. 2012;91(11):1011\u201318. https:\/\/doi.org\/10.1177\/0022034512461016.","journal-title":"J Dent Res"},{"issue":"10","key":"7786_CR54","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/stem.187","volume":"27","author":"S Kidd","year":"2009","unstructured":"Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. STEM Cells. 2009;27(10):2614\u201323. https:\/\/doi.org\/10.1002\/stem.187.","journal-title":"STEM Cells"},{"issue":"5","key":"7786_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000356731","volume":"198","author":"A Scherzed","year":"2013","unstructured":"Scherzed A, Hackenberg S, Radeloff A, Froelich K, Rak K, Hagen R, et al. Human mesenchymal stem cells promote cancer motility and cytokine secretion in vitro. Cells Tissues Organs. 2013;198(5):327\u201337. https:\/\/doi.org\/10.1159\/000356731.","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"7786_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3892\/ijo.2015.3009","volume":"47","author":"A Scherzad","year":"2015","unstructured":"Scherzad A, Steber M, Gehrke T, Rak K, Froelich K, Schendzielorz P, et al. Human mesenchymal stem cells enhance cancer cell proliferation via IL-6 secretion and activation of ERK1\/2. Int J Oncol. 2015;47(1):391\u201397. https:\/\/doi.org\/10.3892\/ijo.2015.3009.","journal-title":"Int J Oncol"},{"issue":"1","key":"7786_CR57","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neo.2020.11.012","volume":"23","author":"C Liu","year":"2021","unstructured":"Liu C, Billet S, Choudhury D, Cheng R, Haldar S, Fernandez A, et al. Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance. Neoplasia. 2021;23(1):118\u201328. https:\/\/doi.org\/10.1016\/j.neo.2020.11.012.","journal-title":"Neoplasia"},{"issue":"3","key":"7786_CR58","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/cas.13479","volume":"109","author":"C Liu","year":"2018","unstructured":"Liu C, Feng X, Wang B, Wang X, Wang C, Yu M, et al. Bone marrow mesenchymal stem cells promote head and neck cancer progression through periostin-mediated phosphoinositide 3-kinase\/akt\/mammalian target of rapamycin. Cancer Sci. 2018;109(3):688\u201398. https:\/\/doi.org\/10.1111\/cas.13479.","journal-title":"Cancer Sci"},{"key":"7786_CR59","doi-asserted-by":"publisher","unstructured":"Raj AT, Kheur S, Khurshid Z, Sayed ME, Mugri MH, Almasri MA, et al. The growth factors and cytokines of dental pulp mesenchymal stem cell secretome may potentially aid in oral cancer proliferation. Molecules. 2021;26(18). https:\/\/doi.org\/10.3390\/molecules26185683.","DOI":"10.3390\/molecules26185683"},{"issue":"8","key":"7786_CR60","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.7150\/jca.37932","volume":"11","author":"J Zeng","year":"2020","unstructured":"Zeng J, Chen S, Li C, Ye Z, Lin B, Liang Y, et al. Mesenchymal stem\/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression. J Cancer. 2020;11(8):2068\u201379. https:\/\/doi.org\/10.7150\/jca.37932.","journal-title":"J Cancer"},{"issue":"4","key":"7786_CR61","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/odi.14617","volume":"30","author":"C Liu","year":"2024","unstructured":"Liu C, Zhou J, Zhang S, Fu J, Li Y, Hao Y, et al. Mesenchymal stem cells-derived IL-6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK-STAT3 signalling. Oral Dis. 2024;30(4):2097\u2013109. https:\/\/doi.org\/10.1111\/odi.14617.","journal-title":"Oral Dis"},{"key":"7786_CR62","doi-asserted-by":"publisher","unstructured":"Bai Y, Sha J, Kanno T. The role of carcinogenesis-related biomarkers in the Wnt pathway and their effects on epithelial-mesenchymal transition (EMT) in oral squamous cell carcinoma. Cancers (Basel). 2020;12(3). https:\/\/doi.org\/10.3390\/cancers12030555.","DOI":"10.3390\/cancers12030555"},{"key":"7786_CR63","doi-asserted-by":"publisher","unstructured":"Sinha S, Narjus-Sterba M, Tuomainen K, Kaur S, Sepp\u00e4nen-Kaijansinkko R, Salo T, et al. Adipose-derived mesenchymal stem cells do not affect the invasion and migration potential of oral squamous carcinoma cells. Int J Mol Sci. 2020;21(18). https:\/\/doi.org\/10.3390\/ijms21186455.","DOI":"10.3390\/ijms21186455"},{"issue":"5","key":"7786_CR64","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00784-014-1338-7","volume":"19","author":"F B\u00f6hrnsen","year":"2015","unstructured":"B\u00f6hrnsen F, Fricke M, Sander C, Leha A, Schliephake H, Kramer FJ. Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition. Clin Oral Investig. 2015;19(5):1121\u201328. https:\/\/doi.org\/10.1007\/s00784-014-1338-7.","journal-title":"Clin Oral Investig"},{"issue":"2","key":"7786_CR65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3342\/ceo.2012.5.2.86","volume":"5","author":"YS Lim","year":"2012","unstructured":"Lim YS, Lee JC, Lee YS, Lee BJ, Wang SG. Growth inhibitory effect of Palatine tonsil-derived mesenchymal stem cells on head and neck squamous cell carcinoma cells. Clin Exp Otorhinolaryngol. 2012;5(2):86\u201393. https:\/\/doi.org\/10.3342\/ceo.2012.5.2.86.","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"4","key":"7786_CR66","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.bbrc.2009.01.031","volume":"379","author":"S Morikawa","year":"2009","unstructured":"Morikawa S, Mabuchi Y, Niibe K, Suzuki S, Nagoshi N, Sunabori T, et al. Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun. 2009;379(4):1114\u201319. https:\/\/doi.org\/10.1016\/j.bbrc.2009.01.031.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"7786_CR67","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2008.03.005","volume":"2","author":"N Nagoshi","year":"2008","unstructured":"Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, Satoh E, et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell STEM Cell. 2008;2(4):392\u2013403. https:\/\/doi.org\/10.1016\/j.stem.2008.03.005.","journal-title":"Cell STEM Cell"},{"issue":"7","key":"7786_CR68","doi-asserted-by":"publisher","first-page":"e0177962","DOI":"10.1371\/journal.pone.0177962","volume":"12","author":"C Coste","year":"2017","unstructured":"Coste C, Neirinckx V, Sharma A, Agirman G, Rogister B, Foguenne J, et al. Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues. PLoS One. 2017;12(7):e0177962. https:\/\/doi.org\/10.1371\/journal.pone.0177962.","journal-title":"PLoS One"},{"key":"7786_CR69","doi-asserted-by":"publisher","unstructured":"Yang T, Tang S, Peng S, Ding G. The effects of mesenchymal stem cells on oral cancer and possible therapy regime. Front Genet. 2022;13(949770). https:\/\/doi.org\/10.3389\/fgene.2022.949770.","DOI":"10.3389\/fgene.2022.949770"},{"key":"7786_CR70","doi-asserted-by":"publisher","unstructured":"Roato I, Chinig\u00f2 G, Genova T, Munaron L, Mussano F. Oral cavity as a source of mesenchymal stem cells useful for regenerative medicine in dentistry. Biomedicines. 2021;9(9). https:\/\/doi.org\/10.3390\/biomedicines9091085.","DOI":"10.3390\/biomedicines9091085"},{"key":"7786_CR71","doi-asserted-by":"publisher","first-page":"686337","DOI":"10.3389\/froh.2021.686337","volume":"2","author":"KJ Bienkowska","year":"2021","unstructured":"Bienkowska KJ, Hanley CJ, Thomas GJ. Cancer-associated fibroblasts in oral cancer: a current perspective on function and potential for therapeutic targeting. Front Oral Health. 2021;2:686337. https:\/\/doi.org\/10.3389\/froh.2021.686337.","journal-title":"Front Oral Health"},{"key":"7786_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2021.03.009","volume":"507","author":"G Wang","year":"2021","unstructured":"Wang G, Zhang M, Cheng M, Wang X, Li K, Chen J, et al. Tumor microenvironment in head and neck squamous cell carcinoma: functions and regulatory mechanisms. Cancer Lett. 2021;507:55\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2021.03.009.","journal-title":"Cancer Lett"},{"issue":"5","key":"7786_CR73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/jop.12098","volume":"43","author":"J Wang","year":"2014","unstructured":"Wang J, Min A, Gao S, Tang Z. Genetic regulation and potentially therapeutic application of cancer-associated fibroblasts in oral cancer. J Oral Pathol Med. 2014;43(5):323\u201334. https:\/\/doi.org\/10.1111\/jop.12098.","journal-title":"J Oral Pathol Med"},{"key":"7786_CR74","doi-asserted-by":"publisher","first-page":"1240159","DOI":"10.3389\/fcell.2023.1240159","volume":"11","author":"J Arebro","year":"2023","unstructured":"Arebro J, Towle R, Lee CM, Bennewith KL, Garnis C. Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer. Front Cell Dev Biol. 2023;11:1240159. https:\/\/doi.org\/10.3389\/fcell.2023.1240159.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"7786_CR75","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","volume":"39","author":"C Hutton","year":"2021","unstructured":"Hutton C, Heider F, Blanco-Gomez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;39(9):1227\u201344.e1220. https:\/\/doi.org\/10.1016\/j.ccell.2021.06.017.","journal-title":"Cancer Cell"},{"issue":"13","key":"7786_CR76","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/0008-5472.Can-12-4150","volume":"73","author":"DE Costea","year":"2013","unstructured":"Costea DE, Hills A, Osman AH, Thurlow J, Kalna G, Huang X, et al. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. Cancer Res. 2013;73(13):3888\u2013901. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-4150.","journal-title":"Cancer Res"},{"issue":"2","key":"7786_CR77","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1158\/2159-8290.Cd-21-0601","volume":"12","author":"EJ Helms","year":"2022","unstructured":"Helms EJ, Berry MW, Chaw RC, DuFort CC, Sun D, Onate MK, et al. Mesenchymal lineage heterogeneity underlies nonredundant functions of pancreatic cancer-associated fibroblasts. Cancer Discov. 2022;12(2):484\u2013501. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0601.","journal-title":"Cancer Discov"},{"key":"7786_CR78","doi-asserted-by":"publisher","unstructured":"Arebro J, Lee CM, Bennewith KL, Garnis C. Cancer-associated fibroblast heterogeneity in malignancy with focus on oral squamous cell carcinoma. Int J Mol Sci. 2024;25(2). https:\/\/doi.org\/10.3390\/ijms25021300.","DOI":"10.3390\/ijms25021300"},{"issue":"7","key":"7786_CR79","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp & Mol Med. 2023;55(7):1322\u201332.","journal-title":"Exp & Mol Med"},{"issue":"5","key":"7786_CR80","doi-asserted-by":"publisher","first-page":"262","DOI":"10.21037\/atm-22-407","volume":"10","author":"B Hu","year":"2022","unstructured":"Hu B, Wu C, Mao H, Gu H, Dong H, Yan J, et al. Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma. Ann Transl Med. 2022;10(5):262. https:\/\/doi.org\/10.21037\/atm-22-407.","journal-title":"Ann Transl Med"},{"issue":"9","key":"7786_CR81","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ccell.2025.06.021","volume":"43","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ling L, Murad R, Maganti S, Manceau A, Hetrick HA, et al. Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer. Cancer Cell. 2025;43(9):1677\u201396. e 1615.","journal-title":"Cancer Cell"},{"issue":"8","key":"7786_CR82","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"issue":"3","key":"7786_CR83","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"7786_CR84","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14(9):587. https:\/\/doi.org\/10.1038\/s41419-023-06110-6.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7786_CR85","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14(1):54. https:\/\/doi.org\/10.1186\/s40164-025-00647-2.","journal-title":"Exp Hematol Oncol"},{"issue":"14","key":"7786_CR86","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.Can-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, et al. FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76(14):4124\u201335. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-2973.","journal-title":"Cancer Res"},{"issue":"4","key":"7786_CR87","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1038\/cddis.2014.122","volume":"5","author":"H Wang","year":"2014","unstructured":"Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 2014;5(4):e1155. https:\/\/doi.org\/10.1038\/cddis.2014.122.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7786_CR88","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao Z, Quazi S, Arora S, Osellame LD, Burvenich IJ, Janes PW, et al. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. J Biomed Sci. 2025;32(1):7. https:\/\/doi.org\/10.1186\/s12929-024-01099-2.","journal-title":"J Biomed Sci"},{"issue":"1","key":"7786_CR89","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","volume":"19","author":"JY Zhang","year":"2021","unstructured":"Zhang JY, Zhu WW, Wang MY, Zhai RD, Wang Q, Shen WL, et al. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness. J Transl Med. 2021;19(1):513. https:\/\/doi.org\/10.1186\/s12967-021-03181-x.","journal-title":"J Transl Med"},{"issue":"1","key":"7786_CR90","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-019-0362-2","volume":"17","author":"Z Wang","year":"2019","unstructured":"Wang Z, Tang Y, Tan Y, Wei Q, Yu W. Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities. Cell Commun Signal. 2019;17(1):47. https:\/\/doi.org\/10.1186\/s12964-019-0362-2.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"7786_CR91","doi-asserted-by":"publisher","first-page":"e0154645","DOI":"10.1371\/journal.pone.0154645","volume":"11","author":"VK Kartha","year":"2016","unstructured":"Kartha VK, Stawski L, Han R, Haines P, Gallagher G, Noonan V, et al. PDGFR\u03b2 is a novel marker of stromal activation in oral squamous cell carcinomas. PLoS One. 2016;11(4):e0154645. https:\/\/doi.org\/10.1371\/journal.pone.0154645.","journal-title":"PLoS One"},{"issue":"9","key":"7786_CR92","doi-asserted-by":"publisher","first-page":"15581","DOI":"10.1002\/jcp.28205","volume":"234","author":"Y Jing","year":"2019","unstructured":"Jing Y, Jin Y, Wang Y, Chen S, Zhang X, Song Y, et al. SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K\/AKT\/PDGFB\/PDGFR\u03b2 axis. J Cell Physiol. 2019;234(9):15581\u201393. https:\/\/doi.org\/10.1002\/jcp.28205.","journal-title":"J Cell Physiol"},{"issue":"7","key":"7786_CR93","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.21873\/anticanres.17674","volume":"45","author":"S Won","year":"2025","unstructured":"Won S, Hah YS, Cheon SY, Yim CD, Park SW, Lee SJ, et al. Periostin promotes invasiveness and metastasis of oral cancer via epithelial-mesenchymal transition. Anticancer Res. 2025;45(7):3099\u2013115. https:\/\/doi.org\/10.21873\/anticanres.17674.","journal-title":"Anticancer Res"},{"key":"7786_CR94","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.matbio.2014.04.007","volume":"37","author":"AY Liu","year":"2014","unstructured":"Liu AY, Zheng H, Ouyang G. Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol. 2014;37:150\u201356. https:\/\/doi.org\/10.1016\/j.matbio.2014.04.007.","journal-title":"Matrix Biol"},{"issue":"23","key":"7786_CR95","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1007\/s00018-017-2646-2","volume":"74","author":"D Cui","year":"2017","unstructured":"Cui D, Huang Z, Liu Y, Ouyang G. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression. Cell Mol Life Sci. 2017;74(23):4287\u201391. https:\/\/doi.org\/10.1007\/s00018-017-2646-2.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"7786_CR96","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18(1):70. https:\/\/doi.org\/10.1186\/s12943-019-0994-2.","journal-title":"Mol Cancer"},{"issue":"1","key":"7786_CR97","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2741\/3613","volume":"15","author":"F Xing","year":"2010","unstructured":"Xing F, Saidou J, Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed), 2010;15(1):166\u201379. https:\/\/doi.org\/10.2741\/3613.","journal-title":"Front Biosci"},{"issue":"10","key":"7786_CR98","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.labinv.2023.100228","volume":"103","author":"K Kayamori","year":"2023","unstructured":"Kayamori K, Katsube KI, Hirai H, Harada H, Ikeda T. Role of stromal fibroblast-induced WNT7A associated with cancer cell migration through the AKT\/CLDN1 signaling axis in oral squamous cell carcinoma. Lab Invest. 2023;103(10):100228. https:\/\/doi.org\/10.1016\/j.labinv.2023.100228.","journal-title":"Lab Invest"},{"issue":"3","key":"7786_CR99","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13402-021-00592-2","volume":"44","author":"J Xie","year":"2021","unstructured":"Xie J, Qi X, Wang Y, Yin X, Xu W, Han S, et al. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt\/\u03b2-catenin pathway. Cell Oncol (Dordr). 2021;44(3):661\u201371. https:\/\/doi.org\/10.1007\/s13402-021-00592-2.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"7786_CR100","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-019-1277-x","volume":"38","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jing Y, Ding L, Zhang X, Song Y, Chen S, et al. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway. J Exp Clin Cancer Res. 2019;38(1):274. https:\/\/doi.org\/10.1186\/s13046-019-1277-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"7786_CR101","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1186\/s12885-020-07495-9","volume":"20","author":"YZ An","year":"2020","unstructured":"An YZ, Cho E, Ling J, Zhang X. The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma. BMC Cancer. 2020;20(1):987. https:\/\/doi.org\/10.1186\/s12885-020-07495-9.","journal-title":"BMC Cancer"},{"issue":"5","key":"7786_CR102","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00418-009-0559-3","volume":"131","author":"M Franz","year":"2009","unstructured":"Franz M, Spiegel K, Umbreit C, Richter P, Codina-Canet C, Berndt A, et al. Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma. Histochem Cell Biol. 2009;131(5):651\u201360. https:\/\/doi.org\/10.1007\/s00418-009-0559-3.","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"7786_CR103","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41420-023-01428-8","volume":"9","author":"C Hu","year":"2023","unstructured":"Hu C, Zhang Y, Wu C, Huang Q. Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges. Cell Death Discov. 2023;9(1):124. https:\/\/doi.org\/10.1038\/s41420-023-01428-8.","journal-title":"Cell Death Discov"},{"issue":"8","key":"7786_CR104","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/jop.12172","volume":"43","author":"B Zhou","year":"2014","unstructured":"Zhou B, Chen WL, Wang YY, Lin ZY, Zhang DM, Fan S, et al. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma. J Oral Pathol Med. 2014;43(8):585\u201392. https:\/\/doi.org\/10.1111\/jop.12172.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"7786_CR105","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13046-016-0458-0","volume":"35","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Tao D, Zhang P, Liu X, Zhang Y, Cheng J, et al. Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion. J Exp Clin Cancer Res. 2016;35(1):181. https:\/\/doi.org\/10.1186\/s13046-016-0458-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"7786_CR106","doi-asserted-by":"publisher","first-page":"101236","DOI":"10.1016\/j.tranon.2021.101236","volume":"14","author":"K Haga","year":"2021","unstructured":"Haga K, Yamazaki M, Maruyama S, Kawaharada M, Suzuki A, Hoshikawa E, et al. Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF-\u03b2\/SOX9 axis in cancer progression. Transl Oncol. 2021;14(12):101236. https:\/\/doi.org\/10.1016\/j.tranon.2021.101236.","journal-title":"Transl Oncol"},{"key":"7786_CR107","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.oraloncology.2018.11.002","volume":"88","author":"LY Wei","year":"2019","unstructured":"Wei LY, Lee JJ, Yeh CY, Yang CJ, Kok SH, Ko JY, et al. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1. Oral Oncol. 2019;88:115\u201323. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.11.002.","journal-title":"Oral Oncol"},{"issue":"6","key":"7786_CR108","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/ijc.25358","volume":"127","author":"M Vered","year":"2010","unstructured":"Vered M, Dayan D, Yahalom R, Dobriyan A, Barshack I, Bello IO, et al. Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer. 2010;127(6):1356\u201362. https:\/\/doi.org\/10.1002\/ijc.25358.","journal-title":"Int J Cancer"},{"issue":"7","key":"7786_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11864-016-0412-6","volume":"17","author":"S Schmitz","year":"2016","unstructured":"Schmitz S, Machiels JP. Targeting the tumor environment in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol. 2016;17(7):37. https:\/\/doi.org\/10.1007\/s11864-016-0412-6.","journal-title":"Curr Treat Options Oncol"},{"issue":"7","key":"7786_CR110","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/onc.2017.387","volume":"37","author":"Y Qiao","year":"2018","unstructured":"Qiao Y, Zhang C, Li A, Wang D, Luo Z, Ping Y, et al. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma. Oncogene. 2018;37(7):873\u201383. https:\/\/doi.org\/10.1038\/onc.2017.387.","journal-title":"Oncogene"},{"issue":"9","key":"7786_CR111","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/lary.20569","volume":"119","author":"K Kourelis","year":"2009","unstructured":"Kourelis K, Vandoros G, Kourelis T, Papadas T, Goumas P, Sotiropoulou-Bonikou G. Low COX2 in tumor and upregulation in stroma mark laryngeal squamous cell carcinoma progression. Laryngoscope. 2009;119(9):1723\u201329. https:\/\/doi.org\/10.1002\/lary.20569.","journal-title":"Laryngoscope"},{"key":"7786_CR112","doi-asserted-by":"publisher","first-page":"1099811","DOI":"10.3389\/fonc.2023.1099811","volume":"13","author":"K Jin","year":"2023","unstructured":"Jin K, Qian C, Lin J, Liu B. Cyclooxygenase-2-prostaglandin E2 pathway: a key player in tumor-associated immune cells. Front Oncol. 2023;13:1099811. https:\/\/doi.org\/10.3389\/fonc.2023.1099811.","journal-title":"Front Oncol"},{"issue":"11","key":"7786_CR113","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00262-015-1742-0","volume":"64","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Sakakura K, Kawabata-Iwakawa R, Rokudai S, Toyoda M, Nishiyama M, et al. Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2015;64(11):1407\u201317. https:\/\/doi.org\/10.1007\/s00262-015-1742-0.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"7786_CR114","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/path.4226","volume":"231","author":"SF Chen","year":"2013","unstructured":"Chen SF, Nieh S, Jao SW, Wu MZ, Liu CL, Chang YC, et al. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma. J Pathol. 2013;231(2):180\u201389. https:\/\/doi.org\/10.1002\/path.4226.","journal-title":"J Pathol"},{"key":"7786_CR115","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ebiom.2018.09.006","volume":"36","author":"YY Li","year":"2018","unstructured":"Li YY, Tao YW, Gao S, Li P, Zheng JM, Zhang SE, et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine. 2018;36:209\u201320. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.006.","journal-title":"EBioMedicine"},{"issue":"1","key":"7786_CR116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.oraloncology.2010.10.013","volume":"47","author":"IO Bello","year":"2011","unstructured":"Bello IO, Vered M, Dayan D, Dobriyan A, Yahalom R, Alanen K, et al. Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol. 2011;47(1):33\u201338. https:\/\/doi.org\/10.1016\/j.oraloncology.2010.10.013.","journal-title":"Oral Oncol"},{"key":"7786_CR117","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-37184-5_6","volume":"1234","author":"K Sobierajska","year":"2020","unstructured":"Sobierajska K, Ciszewski WM, Sacewicz-Hofman I, Niewiarowska J. Endothelial cells in the tumor microenvironment. Adv Exp Med Biol. 2020;1234:71\u201386. https:\/\/doi.org\/10.1007\/978-3-030-37184-5_6.","journal-title":"Adv Exp Med Biol"},{"key":"7786_CR118","doi-asserted-by":"publisher","first-page":"1199225","DOI":"10.3389\/fphys.2023.1199225","volume":"14","author":"X Yao","year":"2023","unstructured":"Yao X, Zeng Y. Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance. Front Physiol. 2023;14:1199225. https:\/\/doi.org\/10.3389\/fphys.2023.1199225.","journal-title":"Front Physiol"},{"issue":"9","key":"7786_CR119","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1084\/jem.20021294","volume":"197","author":"SA Luther","year":"2003","unstructured":"Luther SA, Ansel KM, Cyster JG. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J Exp Med. 2003;197(9):1191\u201398. https:\/\/doi.org\/10.1084\/jem.20021294.","journal-title":"J Exp Med"},{"key":"7786_CR120","doi-asserted-by":"publisher","first-page":"1367875","DOI":"10.3389\/fimmu.2024.1367875","volume":"15","author":"P Leone","year":"2024","unstructured":"Leone P, Malerba E, Susca N, Favoino E, Perosa F, Brunori G, et al. Endothelial cells in tumor microenvironment: insights and perspectives. Front Immunol. 2024;15:1367875. https:\/\/doi.org\/10.3389\/fimmu.2024.1367875.","journal-title":"Front Immunol"},{"issue":"9","key":"7786_CR121","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","volume":"14","author":"J Fang","year":"2023","unstructured":"Fang J, Lu Y, Zheng J, Jiang X, Shen H, Shang X, et al. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications. Cell Death Dis. 2023;14(9):586. https:\/\/doi.org\/10.1038\/s41419-023-06119-x.","journal-title":"Cell Death Dis"},{"issue":"20","key":"7786_CR122","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1158\/0008-5472.Can-07-1497","volume":"67","author":"T Kaneko","year":"2007","unstructured":"Kaneko T, Zhang Z, Mantellini MG, Karl E, Zeitlin B, Verhaegen M, et al. Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res. 2007;67(20):9685\u201393. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-1497.","journal-title":"Cancer Res"},{"issue":"10","key":"7786_CR123","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1158\/0008-5472.Can-13-2032","volume":"74","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Dong Z, Lauxen IS, Filho MS, N\u00f6r JE. Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype. Cancer Res. 2014;74(10):2869\u201381. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-2032.","journal-title":"Cancer Res"},{"issue":"11","key":"7786_CR124","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1172\/jci39482","volume":"119","author":"SO Park","year":"2009","unstructured":"Park SO, Wankhede M, Lee YJ, Choi EJ, Fliess N, Choe SW, et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest. 2009;119(11):3487\u201396. https:\/\/doi.org\/10.1172\/jci39482.","journal-title":"J Clin Invest"},{"issue":"3","key":"7786_CR125","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","volume":"117","author":"RD Starke","year":"2011","unstructured":"Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011;117(3):1071\u201380. https:\/\/doi.org\/10.1182\/blood-2010-01-264507.","journal-title":"Blood"},{"issue":"7","key":"7786_CR126","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1182\/blood-2008-05-158584","volume":"113","author":"J Huang","year":"2009","unstructured":"Huang J, Roth R, Heuser JE, Sadler JE. Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood. 2009;113(7):1589\u201397. https:\/\/doi.org\/10.1182\/blood-2008-05-158584.","journal-title":"Blood"},{"issue":"10","key":"7786_CR127","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1111\/jth.14976","volume":"18","author":"S Patmore","year":"2020","unstructured":"Patmore S, Dhami SPS, O\u2019Sullivan JM. Von Willebrand factor and cancer; metastasis and coagulopathies. J Thromb Haemost. 2020;18(10):2444\u201356. https:\/\/doi.org\/10.1111\/jth.14976.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"7786_CR128","doi-asserted-by":"publisher","first-page":"1629865","DOI":"10.1080\/20013078.2019.1629865","volume":"8","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Yao X, Liu X, He X, Li L, Liu X, et al. Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles. 2019;8(1):1629865. https:\/\/doi.org\/10.1080\/20013078.2019.1629865.","journal-title":"J Extracell Vesicles"},{"key":"7786_CR129","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/fcell.2020.00755","volume":"8","author":"X Yao","year":"2020","unstructured":"Yao X, Xie L, Zeng Y. MiR-9 promotes angiogenesis via targeting on sphingosine-1- phosphate receptor 1. Front Cell Dev Biol. 2020;8:755. https:\/\/doi.org\/10.3389\/fcell.2020.00755.","journal-title":"Front Cell Dev Biol"},{"key":"7786_CR130","doi-asserted-by":"publisher","first-page":"790489","DOI":"10.3389\/fbioe.2021.790489","volume":"9","author":"B Guarino","year":"2021","unstructured":"Guarino B, Katari V, Adapala R, Bhavnani N, Dougherty J, Khan M, et al. Tumor-derived extracellular vesicles induce abnormal angiogenesis via TRPV4 downregulation and subsequent activation of YAP and VEGFR2. Front Bioeng Biotechnol. 2021;9:790489. https:\/\/doi.org\/10.3389\/fbioe.2021.790489.","journal-title":"Front Bioeng Biotechnol"},{"issue":"18","key":"7786_CR131","doi-asserted-by":"publisher","first-page":"25849","DOI":"10.18632\/oncotarget.8405","volume":"7","author":"RJ Thoppil","year":"2016","unstructured":"Thoppil RJ, Cappelli HC, Adapala RK, Kanugula AK, Paruchuri S, Thodeti CK. TRPV4 channels regulate tumor angiogenesis via modulation of Rho\/Rho kinase pathway. Oncotarget. 2016;7(18):25849\u201361. https:\/\/doi.org\/10.18632\/oncotarget.8405.","journal-title":"Oncotarget"},{"issue":"2","key":"7786_CR132","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10620-007-9887-0","volume":"53","author":"Y Takami","year":"2008","unstructured":"Takami Y, Higashi M, Kumagai S, Kuo PC, Kawana H, Koda K, et al. The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer. Dig Dis Sci. 2008;53(2):467\u201373. https:\/\/doi.org\/10.1007\/s10620-007-9887-0.","journal-title":"Dig Dis Sci"},{"key":"7786_CR133","doi-asserted-by":"publisher","first-page":"612802","DOI":"10.3389\/fonc.2020.612802","volume":"10","author":"A Hooglugt","year":"2020","unstructured":"Hooglugt A, van der Stoel MM, Boon RA, Huveneers S. Endothelial YAP\/TAZ signaling in angiogenesis and tumor vasculature. Front Oncol. 2020;10:612802. https:\/\/doi.org\/10.3389\/fonc.2020.612802.","journal-title":"Front Oncol"},{"issue":"5","key":"7786_CR134","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.devcel.2017.08.002","volume":"42","author":"X Wang","year":"2017","unstructured":"Wang X, Freire Valls A, Schermann G, Shen Y, Moya IM, Castro L, et al. YAP\/TAZ orchestrate VEGF signaling during developmental angiogenesis. Dev Cell. 2017;42(5):462\u201378.e467. https:\/\/doi.org\/10.1016\/j.devcel.2017.08.002.","journal-title":"Dev Cell"},{"issue":"9","key":"7786_CR135","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1158\/0008-5472.Can-22-2585","volume":"83","author":"X Li","year":"2023","unstructured":"Li X, Wang C, Zhang H, Li Y, Hou D, Liu D, et al. circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma. Cancer Res. 2023;83(9):1459\u201375. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2585.","journal-title":"Cancer Res"},{"issue":"3","key":"7786_CR136","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00540-019-02645-1","volume":"33","author":"T Nishiwada","year":"2019","unstructured":"Nishiwada T, Kawaraguchi Y, Uemura K, Kawaguchi M. Morphine inhibits cell viability and growth via suppression of vascular endothelial growth factor in human oral cancer HSC-3 cells. J Anesth. 2019;33(3):408\u201315. https:\/\/doi.org\/10.1007\/s00540-019-02645-1.","journal-title":"J Anesth"},{"issue":"1","key":"7786_CR137","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12903-024-03852-3","volume":"24","author":"YQ Sun","year":"2024","unstructured":"Sun YQ, Wang B, Zheng LW, Zhao JH, Ren JG. Oral cancer cell to endothelial cell communication via exosomal miR-21\/RMND5A pathway. BMC Oral Health. 2024;24(1):82. https:\/\/doi.org\/10.1186\/s12903-024-03852-3.","journal-title":"BMC Oral Health"},{"issue":"9","key":"7786_CR138","doi-asserted-by":"publisher","first-page":"e21825","DOI":"10.1096\/fj.202100664R","volume":"35","author":"MER Maitland","year":"2021","unstructured":"Maitland MER, Kuljanin M, Wang X, Lajoie GA, Schild-Poulter C. Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex-dependent regulation of glycolysis. Faseb J. 2021;35(9):e21825. https:\/\/doi.org\/10.1096\/fj.202100664R.","journal-title":"Faseb J"},{"issue":"1","key":"7786_CR139","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1080\/21655979.2021.1932222","volume":"12","author":"S He","year":"2021","unstructured":"He S, Zhang W, Li X, Wang J, Chen X, Chen Y, et al. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation. Bioengineered. 2021;12(1):2164\u201374. https:\/\/doi.org\/10.1080\/21655979.2021.1932222.","journal-title":"Bioengineered"},{"issue":"25","key":"7786_CR140","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1091\/mbc.E16-06-0423","volume":"27","author":"M Roszkowska","year":"2016","unstructured":"Roszkowska M, Skupien A, W\u00f3jtowicz T, Konopka A, Gorlewicz A, Kisiel M, et al. CD44: a novel synaptic cell adhesion molecule regulating structural and functional plasticity of dendritic spines. Mol Biol Cell. 2016;27(25):4055\u201366. https:\/\/doi.org\/10.1091\/mbc.E16-06-0423.","journal-title":"Mol Biol Cell"},{"key":"7786_CR141","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.2147\/ott.S95470","volume":"8","author":"H Xu","year":"2015","unstructured":"Xu H, Tian Y, Yuan X, Wu H, Liu Q, Pestell RG, et al. The role of CD44 in epithelial-mesenchymal transition and cancer development. Onco Targets Ther. 2015;8:3783\u201392. https:\/\/doi.org\/10.2147\/ott.S95470.","journal-title":"Onco Targets Ther"},{"key":"7786_CR142","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-7401-6_3","volume":"1692","author":"L Wang","year":"2018","unstructured":"Wang L, Zuo X, Xie K, Wei D. The role of CD44 and cancer stem cells. Methods Mol Biol. 2018;1692:31\u201342. https:\/\/doi.org\/10.1007\/978-1-4939-7401-6_3.","journal-title":"Methods Mol Biol"},{"issue":"20","key":"7786_CR143","doi-asserted-by":"publisher","first-page":"12061","DOI":"10.3390\/ijms232012061","volume":"23","author":"H Zhu","year":"2022","unstructured":"Zhu H, Zhou W, Wan Y, Lu J, Ge K, Jia C. CD44V3, an alternatively spliced form of CD44, promotes pancreatic cancer progression. Int J Mol Sci. 2022;23(20):12061.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7786_CR144","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/cas.16045","volume":"115","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Kobayashi M, Katsumata H, Tokizaki S, Anzai T, Ikeda Y, et al. CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment. Cancer Sci. 2024;115(2):490\u2013506. https:\/\/doi.org\/10.1111\/cas.16045.","journal-title":"Cancer Sci"},{"issue":"7","key":"7786_CR145","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41419-021-03920-4","volume":"12","author":"M Adjuto-Saccone","year":"2021","unstructured":"Adjuto-Saccone M, Soubeyran P, Garcia J, Audebert S, Camoin L, Rubis M, et al. TNF-\u03b1 induces endothelial-mesenchymal transition promoting stromal development of pancreatic adenocarcinoma. Cell Death Dis. 2021;12(7):649. https:\/\/doi.org\/10.1038\/s41419-021-03920-4.","journal-title":"Cell Death Dis"},{"key":"7786_CR146","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","volume":"15","author":"SJ Serrano-Gomez","year":"2016","unstructured":"Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15:18. https:\/\/doi.org\/10.1186\/s12943-016-0502-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"7786_CR147","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12964-023-01207-z","volume":"21","author":"A Oh","year":"2023","unstructured":"Oh A, Pardo M, Rodriguez A, Yu C, Nguyen L, Liang O, et al. NF-\u03baB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Commun Signal. 2023;21(1):291. https:\/\/doi.org\/10.1186\/s12964-023-01207-z.","journal-title":"Cell Commun Signal"},{"issue":"11","key":"7786_CR148","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.7150\/ijms.20414","volume":"14","author":"WE Yang","year":"2017","unstructured":"Yang WE, Hsieh MJ, Lin CW, Kuo CY, Yang SF, Chuang CY, et al. Plasma levels of endothelial cell-specific molecule-1 as a potential biomarker of oral cancer progression. Int J Med Sci. 2017;14(11):1094\u2013100. https:\/\/doi.org\/10.7150\/ijms.20414.","journal-title":"Int J Med Sci"},{"key":"7786_CR149","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1196\/annals.1397.003","volume":"1095","author":"B Popovi\u0107","year":"2007","unstructured":"Popovi\u0107 B, Jeki\u0107 B, Novakovi\u0107 I, Lukovi\u0107 LJ, Tepavcevi\u0107 Z, Jurisi\u0107 V, et al. Bcl-2 expression in oral squamous cell carcinoma. Ann N Y Acad Sci. 2007;1095:19\u201325. https:\/\/doi.org\/10.1196\/annals.1397.003.","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"7786_CR150","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/sj.cdd.4402174","volume":"14","author":"E Karl","year":"2007","unstructured":"Karl E, Zhang Z, Dong Z, Neiva KG, Soengas MS, Koch AE, et al. Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells. Cell Death Differ. 2007;14(9):1657\u201366. https:\/\/doi.org\/10.1038\/sj.cdd.4402174.","journal-title":"Cell Death Differ"},{"issue":"7\u20138","key":"7786_CR151","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.addr.2009.02.006","volume":"61","author":"Z Dong","year":"2009","unstructured":"Dong Z, N\u00f6r JE. Transcriptional targeting of tumor endothelial cells for gene therapy. Adv Drug Delivery Rev. 2009;61(7\u20138):542\u201353.","journal-title":"Adv Drug Delivery Rev"},{"issue":"9","key":"7786_CR152","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3390\/biomedicines12092111","volume":"12","author":"SK Acharya","year":"2024","unstructured":"Acharya SK, Shai S, Choon YF, Gunardi I, Hartanto FK, Kadir K, et al. Cancer stem cells in oral squamous cell carcinoma: a narrative review on experimental characteristics and methodological challenges. Biomedicines. 2024;12(9):2111.","journal-title":"Biomedicines"},{"issue":"8","key":"7786_CR153","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00432-024-05887-z","volume":"150","author":"I Michelon","year":"2024","unstructured":"Michelon I, Nachtigal GC, Dacoregio MI, Moraes A, Moraes M, Piva LS, et al. Treatment options for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma: a systematic review. J Cancer Res Clin Oncol. 2024;150(8):379. https:\/\/doi.org\/10.1007\/s00432-024-05887-z.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"7786_CR154","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/j.1745-7254.2008.00904.x","volume":"29","author":"T Dai","year":"2008","unstructured":"Dai T, Zheng H, Fu G-S. Hypoxia confers protection against apoptosis via the PI3K\/Akt pathway in endothelial progenitor cells. Acta Pharmacologica Sin. 2008;29(12):1425\u201331. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00904.x.","journal-title":"Acta Pharmacologica Sin"},{"issue":"10","key":"7786_CR155","first-page":"742","volume":"6","author":"R Mehra","year":"2008","unstructured":"Mehra R, Cohen RB, Burtness BA. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Clin Adv Hematol Oncol. 2008;6(10):742\u201350.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"6","key":"7786_CR156","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/jop.12717","volume":"47","author":"M Ganjibakhsh","year":"2018","unstructured":"Ganjibakhsh M, Monshizadeh R, Nasimian A, Aminishakib P, Farzaneh P, Tavakoli Shiraji S, et al. Anti-angiogenic efficacy of aflibercept and bevacizumab in primary oral squamous cell carcinoma cells. J Oral Pathol Med. 2018;47(6):575\u201382. https:\/\/doi.org\/10.1111\/jop.12717.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"7786_CR157","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1038\/s41467-022-33080-8","volume":"13","author":"W-T Ju","year":"2022","unstructured":"Ju W-T, Xia R-H, Zhu D-W, Dou S-J, Zhu G-P, Dong M-J, et al. A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nat Commun. 2022;13(1):5378. https:\/\/doi.org\/10.1038\/s41467-022-33080-8.","journal-title":"Nat Commun"},{"key":"7786_CR158","doi-asserted-by":"publisher","first-page":"585710","DOI":"10.3389\/froh.2020.585710","volume":"1","author":"A Chaudhary","year":"2020","unstructured":"Chaudhary A, Bag S, Arora N, Radhakrishnan VS, Mishra D, Mukherjee G. Hypoxic transformation of immune cell metabolism within the microenvironment of oral cancers. Front Oral Health. 2020;1:585710. https:\/\/doi.org\/10.3389\/froh.2020.585710.","journal-title":"Front Oral Health"},{"key":"7786_CR159","doi-asserted-by":"publisher","first-page":"114502","DOI":"10.1016\/j.biopha.2023.114502","volume":"161","author":"L Prieto-Fern\u00e1ndez","year":"2023","unstructured":"Prieto-Fern\u00e1ndez L, Montoro-Jim\u00e9nez I, de Luxan-Delgado B, Otero-Rosales M, Rodrigo JP, Calvo F, et al. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment. Biomed Pharmacother. 2023;161:114502. https:\/\/doi.org\/10.1016\/j.biopha.2023.114502.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"7786_CR160","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12032-024-02422-5","volume":"41","author":"AH Mohamed","year":"2024","unstructured":"Mohamed AH, Ahmed AT, Al Abdulmonem W, Bokov DO, Shafie A, Al-Hetty H, et al. Interleukin-6 serves as a critical factor in various cancer progression and therapy. Med Oncol. 2024;41(7):182. https:\/\/doi.org\/10.1007\/s12032-024-02422-5.","journal-title":"Med Oncol"},{"issue":"1","key":"7786_CR161","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-021-00341-5","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Veeramachaneni N. Targeting interleukin-1\u03b2 and inflammation in lung cancer. Biomark Res. 2022;10(1):5. https:\/\/doi.org\/10.1186\/s40364-021-00341-5.","journal-title":"Biomark Res"},{"key":"7786_CR162","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1196\/annals.1397.014","volume":"1095","author":"YE Kwak","year":"2007","unstructured":"Kwak YE, Jeon NK, Kim J, Lee EJ. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. Ann N Y Acad Sci. 2007;1095:99\u2013112. https:\/\/doi.org\/10.1196\/annals.1397.014.","journal-title":"Ann N Y Acad Sci"},{"key":"7786_CR163","doi-asserted-by":"publisher","first-page":"105977","DOI":"10.1016\/j.phrs.2021.105977","volume":"175","author":"YY Zhang","year":"2022","unstructured":"Zhang YY, Yao YD, Luo JF, Liu ZQ, Huang YM, Wu FC, et al. Microsomal prostaglandin E(2) synthase-1 and its inhibitors: molecular mechanisms and therapeutic significance. Pharmacol Res. 2022;175:105977. https:\/\/doi.org\/10.1016\/j.phrs.2021.105977.","journal-title":"Pharmacol Res"},{"key":"7786_CR164","doi-asserted-by":"publisher","unstructured":"Mishra D, Banerjee D. Secretome of stromal cancer-associated fibroblasts (CAFs): relevance in cancer. Cells. 2023;12(4). https:\/\/doi.org\/10.3390\/cells12040628.","DOI":"10.3390\/cells12040628"},{"issue":"1","key":"7786_CR165","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12935-023-02943-5","volume":"23","author":"HS Budi","year":"2023","unstructured":"Budi HS, Farhood B. Targeting oral tumor microenvironment for effective therapy. Cancer Cell Int. 2023;23(1):101. https:\/\/doi.org\/10.1186\/s12935-023-02943-5.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"7786_CR166","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1111\/j.1349-7006.2008.00978.x","volume":"99","author":"N Kamochi","year":"2008","unstructured":"Kamochi N, Nakashima M, Aoki S, Uchihashi K, Sugihara H, Toda S, et al. Irradiated fibroblast-induced bystander effects on invasive growth of squamous cell carcinoma under cancer-stromal cell interaction. Cancer Sci. 2008;99(12):2417\u201327. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00978.x.","journal-title":"Cancer Sci"},{"issue":"11","key":"7786_CR167","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","volume":"49","author":"D Zboralski","year":"2022","unstructured":"Zboralski D, Hoehne A, Bredenbeck A, Schumann A, Nguyen M, Schneider E, et al. Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. Eur J Nucl Med Mol Imag. 2022;49(11):3651\u201367. https:\/\/doi.org\/10.1007\/s00259-022-05842-5.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"7786_CR168","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/itt.S291767","volume":"10","author":"R Bughda","year":"2021","unstructured":"Bughda R, Dimou P, D\u2019Souza RR, Klampatsa A. Fibroblast activation protein (FAP)-targeted CAR-T cells: launching an attack on tumor stroma. ImmunoTargets Ther. 2021;10:313\u201323. https:\/\/doi.org\/10.2147\/itt.S291767.","journal-title":"ImmunoTargets Ther"},{"key":"7786_CR169","doi-asserted-by":"publisher","first-page":"1113378","DOI":"10.3389\/fphar.2023.1113378","volume":"14","author":"C Zhang","year":"2023","unstructured":"Zhang C, Fei Y, Wang H, Hu S, Liu C, Hu R, et al. Cafs orchestrates tumor immune microenvironment-A new target in cancer therapy? Front Pharmacol. 2023;14:1113378. https:\/\/doi.org\/10.3389\/fphar.2023.1113378.","journal-title":"Front Pharmacol"},{"issue":"6","key":"7786_CR170","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20130110","volume":"210","author":"E Tran","year":"2013","unstructured":"Tran E, Chinnasamy D, Yu Z, Morgan RA, Lee CC, Restifo NP, et al. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. J Exp Med. 2013;210(6):1125\u201335. https:\/\/doi.org\/10.1084\/jem.20130110.","journal-title":"J Exp Med"},{"key":"7786_CR171","doi-asserted-by":"publisher","first-page":"1056337","DOI":"10.3389\/fphar.2022.1056337","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Tian M, Fu Y, Sun Y, Ding L, Zhang X, et al. Halofuginone inhibits tumor migration and invasion by affecting cancer-associated fibroblasts in oral squamous cell carcinoma. Front Pharmacol. 2022;13:1056337. https:\/\/doi.org\/10.3389\/fphar.2022.1056337.","journal-title":"Front Pharmacol"},{"issue":"24","key":"7786_CR172","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1158\/0008-5472.Can-23-2729","volume":"83","author":"S Mukhopadhyay","year":"2023","unstructured":"Mukhopadhyay S, Huang HY, Lin Z, Ranieri M, Li S, Sahu S, et al. Genome-wide CRISPR screens identify multiple synthetic lethal targets that enhance KRASG12C inhibitor efficacy. Cancer Res. 2023;83(24):4095\u2013111. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2729.","journal-title":"Cancer Res"},{"issue":"11","key":"7786_CR173","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.Cd-24-0177","volume":"14","author":"J Dilly","year":"2024","unstructured":"Dilly J, Hoffman MT, Abbassi L, Li Z, Paradiso F, Parent BD, et al. Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer. Cancer Discov. 2024;14(11):2135\u201361. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0177.","journal-title":"Cancer Discov"},{"issue":"2","key":"7786_CR174","doi-asserted-by":"publisher","first-page":"364","DOI":"10.7150\/jca.32436","volume":"11","author":"L Su","year":"2020","unstructured":"Su L, Wang S, Yuan T, Xie X, Fu X, Ji P, et al. Anti-oral squamous cell carcinoma effects of a potent TAZ inhibitor AR-42. J Cancer. 2020;11(2):364\u201373. https:\/\/doi.org\/10.7150\/jca.32436.","journal-title":"J Cancer"},{"issue":"7","key":"7786_CR175","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","volume":"5","author":"EA Chapeau","year":"2024","unstructured":"Chapeau EA, Sansregret L, Galli GG, Ch\u00e8ne P, Wartmann M, Mourikis TP, et al. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer. 2024;5(7):1102\u201320. https:\/\/doi.org\/10.1038\/s43018-024-00754-9.","journal-title":"Nat Cancer"},{"issue":"6","key":"7786_CR176","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s43018-023-00577-0","volume":"4","author":"TJ Hagenbeek","year":"2023","unstructured":"Hagenbeek TJ, Zbieg JR, Hafner M, Mroue R, Lacap JA, Sodir NM, et al. An allosteric pan-TEAD inhibitor blocks oncogenic YAP\/TAZ signaling and overcomes KRAS G12C inhibitor resistance. Nat Cancer. 2023;4(6):812\u201328. https:\/\/doi.org\/10.1038\/s43018-023-00577-0.","journal-title":"Nat Cancer"},{"issue":"6","key":"7786_CR177","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41419-018-0698-3","volume":"9","author":"MH Choe","year":"2018","unstructured":"Choe MH, Yoon Y, Kim J, Hwang S-G, Han Y-H, Kim J-S. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP. Cell Death Disease. 2018;9(6):640. https:\/\/doi.org\/10.1038\/s41419-018-0698-3.","journal-title":"Cell Death Disease"},{"issue":"1","key":"7786_CR178","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13046-022-02403-4","volume":"41","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang Y, Ji H, Ding J, Wang K. The interplay between noncoding RNA and YAP\/TAZ signaling in cancers: molecular functions and mechanisms. J Exp Clin Cancer Res. 2022;41(1):202. https:\/\/doi.org\/10.1186\/s13046-022-02403-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"14","key":"7786_CR179","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.7150\/jca.115847","volume":"16","author":"Y Soe","year":"2025","unstructured":"Soe Y, Kawai H, Eain HS, Yoshida S, Oo MW, Min ZZ, et al. CXCR4 inhibition induces tumor necrosis by selectively targeting the proliferating blood vessels in oral squamous cell carcinoma. J Cancer. 2025;16(14):4055\u201370. https:\/\/doi.org\/10.7150\/jca.115847.","journal-title":"J Cancer"},{"issue":"7","key":"7786_CR180","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.1007\/s13277-015-4629-y","volume":"37","author":"E Bagordakis","year":"2016","unstructured":"Bagordakis E, Sawazaki-Calone I, Macedo CC, Carnielli CM, de Oliveira CE, Rodrigues PC, et al. Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures. Tumour Biol. 2016;37(7):9045\u201357. https:\/\/doi.org\/10.1007\/s13277-015-4629-y.","journal-title":"Tumour Biol"},{"key":"7786_CR181","doi-asserted-by":"publisher","first-page":"1149662","DOI":"10.3389\/fbioe.2023.1149662","volume":"11","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu J, Liu S, Yu L, Liu S, Li M, et al. Extracellular vesicles in oral squamous cell carcinoma: current progress and future prospect. Front Bioeng Biotechnol. 2023;11:1149662. https:\/\/doi.org\/10.3389\/fbioe.2023.1149662.","journal-title":"Front Bioeng Biotechnol"},{"issue":"8","key":"7786_CR182","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.7150\/ijms.74109","volume":"19","author":"K Ono","year":"2022","unstructured":"Ono K, Sato K, Nakamura T, Yoshida Y, Murata S, Yoshida K, et al. Reproduction of the antitumor effect of cisplatin and cetuximab using a three-dimensional spheroid model in oral cancer. Int J Med Sci. 2022;19(8):1320\u201333. https:\/\/doi.org\/10.7150\/ijms.74109.","journal-title":"Int J Med Sci"},{"issue":"4","key":"7786_CR183","doi-asserted-by":"publisher","first-page":"784","DOI":"10.21037\/tcr-22-2704","volume":"12","author":"B Yu","year":"2023","unstructured":"Yu B, Li R, Zhu X, Chi Z. The influence of antibody CD166 on the treatment of tumor and the immunological mechanism in mice bearing oral squamous cell carcinoma. Transl Cancer Res. 2023;12(4):784\u201392. https:\/\/doi.org\/10.21037\/tcr-22-2704.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"7786_CR184","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12903-023-03602-x","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu Y, Chen L, Feng C, Wang T, He S, Zheng D, et al. Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3. BMC Oral Health. 2023;23(1):846. https:\/\/doi.org\/10.1186\/s12903-023-03602-x.","journal-title":"BMC Oral Health"},{"issue":"1","key":"7786_CR185","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s43556-025-00340-0","volume":"6","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Zhang H, Gao Y, Sun Y. Multi-omics strategies for biomarker discovery and application in personalized oncology. Mol Biomed. 2025;6(1):115. https:\/\/doi.org\/10.1186\/s43556-025-00340-0.","journal-title":"Mol Biomed"},{"issue":"4","key":"7786_CR186","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ccell.2025.03.012","volume":"43","author":"J Luo","year":"2025","unstructured":"Luo J, Solit DB. Leveraging real-world data to advance biomarker discovery and precision oncology. Cancer Cell. 2025;43(4):606\u201310. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.012.","journal-title":"Cancer Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07786-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:02:42Z","timestamp":1772794962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07786-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":186,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7786"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07786-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}